Literature DB >> 9871454

Glutamate release inhibitors: a critical assessment of their action mechanism.

T P Obrenovitch1, J Urenjak.   

Abstract

A number of important experimental data do not support the widespread hypothesis that Na(+)-channels block is cerebroprotective, essentially because it reduces presynaptic glutamate release: (i) the inhibition of exocytosis by these compounds is not specific to glutamate; (ii) aspartate efflux produced by various stimuli was also reduced, but aspartate cannot be released by exocytosis because it is not concentrated within presynaptic vesicles; and (iii) glutamate accumulated extracellularly during ischaemic or traumatic insult to the CNS is mainly of cytosolic origin. As an alternative, we propose that use-dependent Na(+)-channel blockers enhance the resistance of nerve cells to insults, primarily by decreasing their energy demand, and that reduced efflux of glutamate and other compounds is a consequence of attenuated cellular stress.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9871454     DOI: 10.1007/bf01345255

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  4 in total

1.  Effects of riluzole on electrically evoked neurotransmitter release.

Authors:  T Jehle; J Bauer; E Blauth; A Hummel; M Darstein; T M Freiman; T J Feuerstein
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Regional differences in the effects of isoflurane on neurotransmitter release.

Authors:  Robert I Westphalen; No-Bong Kwak; Keir Daniels; Hugh C Hemmings
Journal:  Neuropharmacology       Date:  2011-05-30       Impact factor: 5.250

3.  Neuroprotective effects of NS-7, voltage-gated Na+/Ca2+ channel blocker in a rodent model of transient focal ischaemia.

Authors:  Monika Sopala; Wojciech Danysz; Guenter Quack
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

4.  Basal ganglia neuroprotection with anticonvulsants after energy stress: a comparative study.

Authors:  S Arpin; E Lagrue; S Bodard; S Chalon; P Castelnau
Journal:  Metab Brain Dis       Date:  2009-09       Impact factor: 3.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.